BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7093740)

  • 1. Quipazine has a biphasic effect on slow wave sleep and reduces REM sleep rebound in REM sleep deprived rats.
    Zak R; Radulovacki M
    Brain Res Bull; 1982 Mar; 8(3):329-31. PubMed ID: 7093740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep suppressant action of quipazine: relation to central serotonergic stimulation.
    Fornal C; Radulovacki M
    Pharmacol Biochem Behav; 1981 Dec; 15(6):937-44. PubMed ID: 7323120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin receptor activation in rats previously deprived of REM sleep.
    Santos R; Carlini EA
    Pharmacol Biochem Behav; 1983 Apr; 18(4):501-7. PubMed ID: 6602989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methysergide blocks the sleep suppressant action of quipazine in rats.
    Fornal C; Radulovacki M
    Psychopharmacology (Berl); 1982; 76(3):255-9. PubMed ID: 6808546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. REM sleep deprivation changes behavioral response to catecholaminergic and serotonergic receptor activation in rats.
    Mogilnicka E
    Pharmacol Biochem Behav; 1981 Jul; 15(1):149-51. PubMed ID: 7197363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased waking as well as increased synchronization following administration of selective 5-HT uptake inhibitors to rats.
    Ursin R; Bjorvatn B; Sommerfelt L; Underland G
    Behav Brain Res; 1989 Aug; 34(1-2):117-30. PubMed ID: 2527519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platform sleep deprivation affects deep slow wave sleep in addition to REM sleep.
    Grahnstedt S; Ursin R
    Behav Brain Res; 1985 Dec; 18(3):233-9. PubMed ID: 4091961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of zimeldine, a selective 5-HT reuptake inhibitor, combined with ritanserin, a selective 5-HT2 antagonist, on waking and sleep stages in rats.
    Bjorvatn B; Ursin R
    Behav Brain Res; 1990 Nov; 40(3):239-46. PubMed ID: 2149499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the activation of MCH and orexin immunorective neurons and REM sleep architecture during REM rebound after a three day long REM deprivation.
    Kitka T; Adori C; Katai Z; Vas S; Molnar E; Papp RS; Toth ZE; Bagdy G
    Neurochem Int; 2011 Oct; 59(5):686-94. PubMed ID: 21740944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of the cannabinoid receptor CB1 in rapid eye movement sleep rebound.
    Navarro L; Martínez-vargas M; Murillo-rodríguez E; Landa A; Méndez-díaz M; Prospéro-garcía O
    Neuroscience; 2003; 120(3):855-9. PubMed ID: 12895525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muramyl dipeptide does not induce slow-wave sleep or fever in rats.
    Fornal C; Markus R; Radulovacki M
    Peptides; 1984; 5(1):91-5. PubMed ID: 6709515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. REM-sleep deprivation-induced increase in ethanol intake: role of brain monoaminergic neurons.
    Aalto J; Kiianmaa K
    Alcohol; 1986; 3(6):377-81. PubMed ID: 3814349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of methysergide in cats deprived of paradoxical sleep.
    Jackman H; Radulovacki M
    Res Commun Chem Pathol Pharmacol; 1976 Nov; 15(3):425-33. PubMed ID: 186853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous behavior and sleep-wakefulness cycle in isolated and paired REM sleep deprived-marihuana treated rats.
    Monti JM; Carlini EA
    Pharmacol Biochem Behav; 1975; 3(6):1025-9. PubMed ID: 177995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
    Eison AS; Eison MS; Yocca FD; Gianutsos G
    Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological models of depression: effect of antidepressants on sleep].
    Viot-Blanc V
    Encephale; 1995 Dec; 21 Spec No 7():35-40. PubMed ID: 8929677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of REM sleep rebound in rats by alpha-adrenoreceptor blockers, phentolamine and phenoxybenzamine.
    Radulovacki M; Wojcik WJ; Fornal C; Miletich R
    Pharmacol Biochem Behav; 1980 Jul; 13(1):51-5. PubMed ID: 7403221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic escitalopram treatment attenuated the accelerated rapid eye movement sleep transitions after selective rapid eye movement sleep deprivation: a model-based analysis using Markov chains.
    Kostyalik D; Vas S; Kátai Z; Kitka T; Gyertyán I; Bagdy G; Tóthfalusi L
    BMC Neurosci; 2014 Nov; 15():120. PubMed ID: 25406958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of auditory stimulation during recovery after REM sleep deprivation.
    Salín-Pascual RJ; Jiménez-Anguiano A; Durán-Vazquez A; Nancy HM; Drucker-Colín R
    Sleep; 1994 Apr; 17(3):231-5. PubMed ID: 7939122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphetamine abolishes REM sleep rebound in rats: effect of single injection.
    Radulovacki M; Zak R
    Brain Res; 1981 Aug; 217(2):420-4. PubMed ID: 7248800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.